Phase 1 trial of CAR T-cell therapy for lymphoma - 101793

Spotlight
Video

Phase 1 trial of CAR T-cell therapy for lymphoma

VJHemOnc has 1040 videos Subscribe Here

Loading........
Description: At the 58th American Society of Hematology (ASH) Annual Meeting & Exposition, Catherine Bollard, MBChB, MD, FRACP, FRCPA, from Children's National Medical Center, Washington, DC, discusses the initial analysis of a phase 1 dose escalation study of activated autologous CD30-specific chimeric antigen receptors (CAR) T cells infused in patients with relapsed or refractory CD30-positive Hodgkin lymphoma or non-Hodgkin lymphoma.
Shared By : VJHemOnc
Posted on : 02/10/16
Added : 2 years ago
Category : Lymphoma